Edition:
United States

Medtronic PLC (MDT)

MDT on New York Consolidated

80.04USD
21 Sep 2017
Change (% chg)

$-0.12 (-0.15%)
Prev Close
$80.16
Open
$80.14
Day's High
$80.16
Day's Low
$79.97
Volume
109,030
Avg. Vol
4,603,656
52-wk High
$89.72
52-wk Low
$69.35

Select another date:

BRIEF-Medtronic announces clinical study to evaluate its Corevalve Evolut pro system in 'everyday' clinical practice

* Medtronic announces clinical study to evaluate the Corevalve Evolut pro system in 'everyday' clinical practice

BRIEF-Medtronic announces FDA approval, U.S. launch of spinal cord stimulator

* Medtronic announces FDA approval and U.S. launch of next generation spinal cord stimulator for chronic pain management Source text for Eikon: Further company coverage:

BRIEF-New five-year gender subset data from the Medtronic engage registry presented in viva late breaking trials

* New five-year gender subset data from the medtronic engage registry presented in viva late breaking trials

BRIEF-Medtronic plc ‍announces global launch of StealthStation ENT​

* Medtronic Plc - ‍announced global launch of StealthStation ENT​ Source text for Eikon: Further company coverage:

BRIEF-Medtronic announces voluntary recall of diabetes infusion sets

* Medtronic announces voluntary recall of diabetes infusion sets

UPDATE 1-Medtronic to recall some diabetes infusion sets

Sept 11 Medical device maker Medtronic Plc said on Monday it would recall certain infusion sets used with its insulin pumps by diabetes patients due to a component that could cause death in extreme cases.

Medtronic to recall diabetes infusion sets

Sept 11 Medtronic Plc on Monday said that it would recall certain infusion sets used with all its insulin pumps due to a discontinued component.

BRIEF-Medtronic announces Japanese regulatory approval for IN.PACT Admiral drug-coated balloon

* Medtronic announces japanese regulatory approval for the IN.PACT Admiral drug-coated balloon

BRIEF-Medtronic launches long term clinical study program of infuse bone graft in 2 common spine procedures PLF, TLIF

* Medtronic launches long term clinical study program of infuse bone graft in two common spine procedures: PLF and TLIF

BRIEF-Mazor Robotics says Medtronic to make $40 million third tranche investment in Mazor

* Mazor Robotics and Medtronic enter next phase of strategic partnership; Medtronic to make a $40 million third tranche investment in Mazor

Select another date: